This individual will focus on genetic kidney diseases (GKD), including APOL1-mediated kidney disease (AMKD) and autosomal dominant polycystic kidney disease (ADPKD), and provide quantitative and qualitative forecasting and analytical support for key commercial processes and business decisions.
Base: $192,200 - $288,400; Bonus/Equity: Eligible for annual bonus and annual equity awards; Benefits: Market-leading benefits
Must-have
Nice-to-have
Not specified